Engineered Macrophages Emerge as a New Frontier in Cell Therapy for Solid Tumors
A new review details how chimeric antigen receptor-engineered macrophages are overcoming the barriers that stalled CAR-T therapy in solid tumors, ...
A new review details how chimeric antigen receptor-engineered macrophages are overcoming the barriers that stalled CAR-T therapy in solid tumors, ...
A new review proposes co-designing oncolytic viruses and CAR-T or CAR-NK cells as a modular, self-amplifying therapeutic system to overcome ...
A small German cohort study reports that injecting a slow-release TLR7/8 agonist into oral tumors before surgery, combined with systemic ...
Scientists have engineered red blood cell-hitchhiking liposomes that co-deliver hemoglobin and paclitaxel to lung metastases, reversing hypoxia-driven drug resistance and ...
Researchers have identified a bone marrow-derived CD11c-positive B220-positive NK cell subset selectively expanded by IL-15 that outperforms conventional NK cells ...
A new review in Molecular Cancer maps the diverse states of cancer-associated fibroblasts and argues that precisely modulating, rather than ...
A new biodegradable nanoparticle called HILA continuously drains tumors of lactate while orchestrating starvation, chemodynamic, photodynamic, and photothermal therapy against ...
Researchers found that inhibiting the RNA editing enzyme ADAR1 reprograms the immunosuppressive tumor microenvironment of bladder cancer and sensitizes it ...
New research shows that lung tumors become radioresistant through ATR signaling activation and immune suppression, but innate immune agonists and ...
A new study shows that the lipid receptor OLR1 drives gastric cancer progression by activating NF-κB signaling and polarizing macrophages ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine